702 filings
DEF 14A
VTGN
VistaGen Therapeutics Inc
Definitive proxy
15 Apr 24
9:52pm
PRE 14A
VTGN
VistaGen Therapeutics Inc
Preliminary proxy
5 Apr 24
5:29pm
8-K
VTGN
VistaGen Therapeutics Inc
1 Apr 24
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder following Positive Results of PALISADE-2
5:25pm
4
Mary L. Rotunno
6 Mar 24
Vistagen Therapeutics / Mary L. Rotunno ownership change
6:00pm
4
Gin Jerry B
6 Mar 24
Vistagen Therapeutics / JERRY B GIN ownership change
6:00pm
4
6wdoqw0
6 Mar 24
Vistagen Therapeutics / Margaret M FitzPatrick ownership change
6:00pm
4
xcamv9ba7qv7 awg1v
6 Mar 24
Vistagen Therapeutics / Joanne Curley ownership change
6:00pm
4
xvg27w 2785r7juy
6 Mar 24
Vistagen Therapeutics / Ann Michelle Cunningham ownership change
6:00pm
4
6bumb4y3
6 Mar 24
Vistagen Therapeutics / JON S SAXE ownership change
6:00pm
EFFECT
s3nttip
1 Mar 24
Notice of effectiveness
12:15am
SC 13G/A
hf2xo3q1zjbfgeql
14 Feb 24
Vistagen Therapeutics / CITADEL ADVISORS ownership change
6:18pm
SC 13G
k6ectms9
14 Feb 24
Vistagen Therapeutics / Nantahala Capital Management ownership change
4:51pm
SC 13G/A
6rdpts0 pjuo
14 Feb 24
Vistagen Therapeutics / GREAT POINT PARTNERS ownership change
4:39pm
SC 13G/A
4jbn3b9xph
14 Feb 24
Vistagen Therapeutics / Point72 Asset Management ownership change
8:56am
SC 13G
4s65trr71 we3
13 Feb 24
Vistagen Therapeutics / VANGUARD ownership change
5:17pm
8-K
pcwcd8
13 Feb 24
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
4:33pm
8-K
vdg8zv49uqdn ixod6z5
8 Jan 24
Regulation FD Disclosure
6:37pm
4
443nkz
3 Jan 24
Vistagen Therapeutics / Reid G. Adler ownership change
5:19pm